Richard Traherne

Head of Next Frontiers | Capgemini Invent Global Leadership Team Richard shapes new strategic innovation areas at Capgemini Invent, bringing together its market-leading scientific, technology and engineering services to pioneer next frontiers. Richard also leads Capgemini’s Engineering Biology business, which offers a comprehensive suite of bioengineering advisory, development and scale-up services. His work leverages the expertise across the company’s innovation brands including next-generation experiences at frog, deep-tech at Cambridge Consultants, physical AI at Synapse, and the wider group. Richard transitioned to Capgemini Invent from its subsidiary Cambridge Consultants, where he served as Chief Commercial Officer directing global growth, client strategy, brand and marketing. With a background in radio frequency electronics and communications, Richard has since expanded his expertise across sectors including consumer, industrial and healthcare. Specialising in collaborating with ambitious businesses that wish to make a significant positive impact, Richard is dedicated to genuine market-changing innovation.

‍

Capgemini Invent

Website

Wednesday

May 07

Making It Happen: Accelerating the Global Bioeconomy:

4:30 PM

5:15 PM

This panel will bring together leaders across industry, public sector and the community to examine the systemic barriers slowing the bioeconomy’s growth and ask, “What best practices are we seeing to unlock progress?” Despite breakthroughs in synbio—including recent our findings showing 96% of businesses are advancing biosolutions—progress remains stalled by discovery costs, scaling challenges, regulatory uncertainty, and investment bottlenecks. Join this session to understand how these challenges are being overcome to ensure synbio moves from future predictions to large-scale impact. The discussion will focus on tangible actions to accelerate this transition and realize the full economic promise of the bioeconomy.